A detailed history of Glenview Capital Management, LLC transactions in Viatris Inc stock. As of the latest transaction made, Glenview Capital Management, LLC holds 7,571,906 shares of VTRS stock, worth $94.8 Million. This represents 1.7% of its overall portfolio holdings.

Number of Shares
7,571,906
Previous 6,494,782 16.58%
Holding current value
$94.8 Million
Previous $69 Million 27.33%
% of portfolio
1.7%
Previous 1.36%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $11.1 Million - $13.1 Million
1,077,124 Added 16.58%
7,571,906 $87.9 Million
Q2 2024

Aug 14, 2024

BUY
$10.05 - $12.02 $13.6 Million - $16.3 Million
1,352,783 Added 26.31%
6,494,782 $69 Million
Q1 2024

May 15, 2024

SELL
$11.27 - $13.53 $10.4 Million - $12.5 Million
-923,048 Reduced 15.22%
5,141,999 $61.4 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $53.2 Million - $65.8 Million
6,065,047 New
6,065,047 $65.7 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Glenview Capital Management, LLC Portfolio

Follow Glenview Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glenview Capital Management, LLC with notifications on news.